TipRanks
BioLife Solutions (BLFS)
NASDAQ:BLFS
US Market
Want to see BLFS full AI Analyst Report?

BioLife Solutions (BLFS) Ratios

419 Followers

BioLife Solutions Ratios

BLFS's free cash flow for Q2 2026 was $0.64. For the 2026 fiscal year, BLFS's free cash flow was decreased by $ and operating cash flow was $0.10. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
9.69 5.94 4.54 2.86 3.11
Quick Ratio
7.14 4.63 3.66 1.83 2.32
Cash Ratio
1.72 1.44 2.91 0.66 0.44
Solvency Ratio
1.97 -0.22 -0.23 -0.72 -1.39
Operating Cash Flow Ratio
1.21 0.88 0.26 -0.30 -0.19
Short-Term Operating Cash Flow Coverage
0.00 4.03 0.77 -1.99 -4.68
Net Current Asset Value
$ 107.71M$ 102.56M$ 98.18M$ 45.55M$ 52.41M
Leverage Ratios
Debt-to-Assets Ratio
0.04 0.04 0.08 0.08 0.10
Debt-to-Equity Ratio
0.04 0.05 0.09 0.10 0.12
Debt-to-Capital Ratio
0.04 0.05 0.08 0.09 0.11
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.01 0.05 0.06
Financial Leverage Ratio
1.07 1.09 1.14 1.22 1.24
Debt Service Coverage Ratio
79.03 0.46 0.13 -5.61 -47.56
Interest Coverage Ratio
11.29 -0.40 -9.92 -39.09 -8.62
Debt to Market Cap
0.00 <0.01 0.01 0.03 0.03
Interest Debt Per Share
0.34 0.43 0.67 0.82 1.05
Net Debt to EBITDA
-0.84 -4.20 -42.57 -0.13 -0.20
Profitability Margins
Gross Profit Margin
64.48%64.56%65.25%32.63%70.60%
EBIT Margin
6.03%-1.12%-8.67%-40.16%-189.06%
EBITDA Margin
9.51%3.75%1.86%-31.58%-162.89%
Operating Profit Margin
7.25%-1.12%-8.67%-49.43%-7.77%
Pretax Profit Margin
7.84%-12.56%-13.89%-46.25%-6.36%
Net Profit Margin
49.06%-12.61%-24.54%-46.36%-183.38%
Continuous Operations Profit Margin
49.06%-12.61%-13.84%-46.36%0.51%
Net Income Per EBT
625.42%100.41%176.67%100.26%2883.77%
EBT Per EBIT
108.21%1117.58%160.26%93.55%81.85%
Return on Assets (ROA)
11.27%-2.99%-5.05%-16.10%-31.05%
Return on Equity (ROE)
13.29%-3.26%-5.78%-19.67%-38.39%
Return on Capital Employed (ROCE)
1.72%-0.28%-1.94%-19.11%-1.46%
Return on Invested Capital (ROIC)
1.71%-0.28%-1.87%-18.73%0.12%
Return on Tangible Assets
21.44%-6.28%-11.36%-39.82%-72.29%
Earnings Yield
2.80%-1.05%-1.69%-9.35%-18.08%
Efficiency Ratios
Receivables Turnover
9.65 12.10 8.97 7.68 2.25
Payables Turnover
14.71 22.94 8.00 13.91 7.02
Inventory Turnover
1.03 1.13 0.99 2.22 3.09
Fixed Asset Turnover
4.31 4.34 4.91 4.39 1.94
Asset Turnover
0.23 0.24 0.21 0.35 0.17
Working Capital Turnover Ratio
0.87 0.84 0.85 1.66 0.86
Cash Conversion Cycle
368.70 337.07 365.55 185.62 228.54
Days of Sales Outstanding
37.81 30.17 40.68 47.53 162.47
Days of Inventory Outstanding
355.70 322.81 370.49 164.33 118.03
Days of Payables Outstanding
24.81 15.91 45.63 26.24 51.97
Operating Cycle
393.51 352.98 411.17 211.87 280.50
Cash Flow Ratios
Operating Cash Flow Per Share
0.35 0.42 0.18 -0.29 -0.20
Free Cash Flow Per Share
-0.02 <0.01 0.11 -0.43 -0.44
CapEx Per Share
0.36 0.41 0.07 0.15 0.24
Free Cash Flow to Operating Cash Flow
-0.05 0.02 0.62 1.51 2.22
Dividend Paid and CapEx Coverage Ratio
0.95 1.02 2.61 -1.96 -0.82
Capital Expenditure Coverage Ratio
0.95 1.02 2.61 -1.96 -0.82
Operating Cash Flow Coverage Ratio
1.07 1.12 0.28 -0.37 -0.19
Operating Cash Flow to Sales Ratio
0.16 0.21 0.10 -0.09 -0.11
Free Cash Flow Yield
-0.05%0.04%0.44%-2.66%-2.44%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
35.64 -96.72 -59.25 -10.69 -5.53
Price-to-Sales (P/S) Ratio
17.51 12.00 14.54 4.96 10.14
Price-to-Book (P/B) Ratio
4.29 3.10 3.43 2.10 2.12
Price-to-Free Cash Flow (P/FCF) Ratio
-1.99K 2.78K 229.80 -37.63 -40.96
Price-to-Operating Cash Flow Ratio
106.70 57.40 141.85 -56.84 -91.08
Price-to-Earnings Growth (PEG) Ratio
-0.01 2.24 0.83 0.20 >-0.01
Price-to-Fair Value
4.29 3.10 3.43 2.10 2.12
Enterprise Value Multiple
183.21 316.01 738.05 -15.84 -6.42
Enterprise Value
1.79B 1.14B 1.13B 716.37M 797.43M
EV to EBITDA
183.21 316.01 738.05 -15.84 -6.42
EV to Sales
17.43 11.84 13.75 5.00 10.46
EV to Free Cash Flow
-1.98K 2.74K 217.27 -37.95 -42.25
EV to Operating Cash Flow
106.19 56.65 134.11 -57.32 -93.94
Tangible Book Value Per Share
4.25 3.33 2.76 2.10 2.53
Shareholders’ Equity Per Share
8.59 7.79 7.57 7.72 8.57
Tax and Other Ratios
Effective Tax Rate
-5.25 >-0.01 <0.01 >-0.01 1.08
Revenue Per Share
2.10 2.01 1.79 3.28 1.79
Net Income Per Share
1.03 -0.25 -0.44 -1.52 -3.29
Tax Burden
6.25 1.00 1.77 1.00 28.84
Interest Burden
1.30 11.18 1.60 1.15 0.03
Research & Development to Revenue
0.08 0.08 0.10 0.13 0.19
SG&A to Revenue
0.54 0.58 0.61 0.39 0.63
Stock-Based Compensation to Revenue
0.13 0.24 0.38 0.22 0.33
Income Quality
1.44 -4.38 -0.42 0.19 0.06
Currency in USD